Kopp, Ryan P.
Beer, Tomasz M. http://orcid.org/0000-0001-5600-9993
Article History
First Online: 18 July 2019
Competing interests
: T.M.B. has received research funding from Alliance Foundation Trials, Boehringer Ingelheim, Corcept Therapeutics, Endocyte Inc., Janssen Research & Development, Medivation, Inc./Astellas, OncoGenex, Sotio and Theraclone Sciences/OncoResponse, consulting fees from AbbVie, Astellas Pharma, AstraZeneca, Bayer, Boehringer Ingelheim, Clovis Oncology, GlaxoSmithKline, Janssen Biotech, Janssen Japan, Merck and Pfizer and owns stock in Salarius Pharmaceuticals. R.P.K. has received research funding from Merck and Roche.